Your browser doesn't support javascript.
loading
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.
Fernandez-Sojo, Jesus; Horton, Roger; Cid, Joan; Azqueta, Carmen; Garcia-Buendia, Ana; Valdivia, Elena; Martorell, Lluis; Rubio-Lopez, Nuria; Codinach, Margarita; Aran, Gemma; Marsal, Julia; Mussetti, Alberto; Martino, Rodrigo; Diaz-de-Heredia, Cristina; Ferra, Christelle; Valcarcel, David; Linares, Mónica; Ancochea, Agueda; García-Rey, Enric; García-Muñoz, Nadia; Medina, Laura; Carreras, Enric; Villa, Juliana; Lozano, Miquel; Gibson, Daniel; Querol, Sergio.
Afiliação
  • Fernandez-Sojo J; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain. jefernandez@bst.cat.
  • Horton R; Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, UK.
  • Cid J; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis ICMHO, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Azqueta C; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Garcia-Buendia A; Data manager and statisticians, cell therapy department, Banc de Sang I Teixits, Barcelona, Spain.
  • Valdivia E; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Martorell L; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Rubio-Lopez N; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Codinach M; Cell Laboratory, Banc de Sang i Teixits, Barcelona, Spain.
  • Aran G; Cell Laboratory, Banc de Sang i Teixits, Barcelona, Spain.
  • Marsal J; Pediatric Hematology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Mussetti A; Adult Hematology Department, Institut Catala d'Oncologia-Hospitalet, Barcelona, Spain.
  • Martino R; Adult Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukemia Research Institute, Universitat Autònoma of Barcelona, Barcelona, Spain.
  • Diaz-de-Heredia C; Department of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
  • Ferra C; Adult Hematology Department, Institut Català d'Oncologia-Badalona, Barcelona, Spain.
  • Valcarcel D; Adult Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Linares M; Banc de Sang i Teixits, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Ancochea A; Banc de Sang i Teixits, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • García-Rey E; Banc de Sang i Teixits, Hospital Sant Joan de Déu, Barcelona, Spain.
  • García-Muñoz N; Banc de Sang i Teixits, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Medina L; Banc de Sang i Teixits, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Carreras E; Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Barcelona, Catalonia, Spain.
  • Villa J; Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Barcelona, Catalonia, Spain.
  • Lozano M; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis ICMHO, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Gibson D; Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, UK.
  • Querol S; Advanced & Cell Therapy Services, Banc de Sang i Teixits, Barcelona, Spain; Transfusion Medicine Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Bone Marrow Transplant ; 57(10): 1531-1538, 2022 10.
Article em En | MEDLINE | ID: mdl-35804055
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article